Bill > HRes172

This resolution highlights the critical challenges surrounding chordoma, a rare and complex bone cancer that affects the skull and spine. The resolution notes that chordoma is a slow-growing yet aggressive cancer that impacts over 25,000 individuals worldwide, with approximately 300 new diagnoses annually in the United States. It emphasizes the significant medical difficulties in treating chordoma, including its location near critical anatomical structures like the brain stem, spinal cord, and major nerves and arteries. The resolution points out that while surgery and radiation can be curative for some patients, the recurrence rate remains high, and currently no drugs exist to effectively cure or control the disease. Consequently, the House of Representatives resolves that increased funding and support are needed in four key areas: improving diagnostic accuracy and early detection, developing new treatments and potential cures, reducing barriers between research and treatment implementation, and adopting patient-centered approaches to drug discovery and development.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-resolution/172/all-info